Trials / Completed
CompletedNCT00418366
A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)
An Open- Label, 2 Part Study to Investigate the Pharmacokinetics, Safety, and Tolerability of MK0431(Sitagliptin Phosphate) in Patients With Varying Degrees of Renal Insufficiency
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A study to evaluate the effect of kidney disease, from mild to severe disease, on a diabetes medication
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0431, sitagliptin phosphate / Duration of Treatment : 1 Days |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2003-03-01
- Completion
- 2003-03-01
- First posted
- 2007-01-04
- Last updated
- 2015-08-19
Source: ClinicalTrials.gov record NCT00418366. Inclusion in this directory is not an endorsement.